Remove accelerator Remove collaboration Remove construction Remove peer-to-peer
article thumbnail

3 key ingredients for successful remote work

Entrepreneurs' Organization

Smuts is currently enrolled in EO’s Accelerator program and the founder of Credo Growth. They recently collaborated on a seminar exploring the key ingredients for successful remote working. The global coronavirus pandemic has forced a widespread shift to remote work. The impact on our families and careers has been significant.

article thumbnail

Racing Against Time: Why Scientists May Use AI ‘Research Assembly Lines’

HPA

Artificial Intelligence (AI) is rapidly outpacing scientific research due to the latter’s inherent limitations. Addressing this issue is crucial to seize significant opportunities. Failure to do so may result in the United States falling behind scientists from other countries.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

We’re disrupting TechCrunch Disrupt: 8 stages, 3 days, 1 city

TechCrunch

It’s time to disrupt TechCrunch Disrupt This year, we’re reimagining and refreshing Disrupt to deliver the essential tools, knowledge, and connections that help ignite ideas and accelerate the next generation of startups. Sessions will include Breakthrough Energy Ventures, S2G, and the City of Atlanta.

article thumbnail

What’s Stripe’s deal?

TechCrunch

Welcome to The Interchange ! If you received this in your inbox, thank you for signing up and your vote of confidence. If you’re reading this as a post on our site, sign up here so you can receive it directly in the future. Every week, I’ll take a look at the hottest fintech news of the previous week.

article thumbnail

Newsletter: Lunar land rush begins

OurCrowd

DayTwo’s science is based on more than seven years of research at the Weizmann Institute, Mayo Clinic and other leading research centers, and has been published in leading peer-reviewed journals including the New England Journal of Medicine and Cell and Nature. OurCrowd has an allocation in this time sensitive Series A round.